We are live on
!
Find out more
UONDDL
University of Notre Dame du Lac Portfolio holdings
AUM
$66.8M
1-Year Est. Return
43.52%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$400M
AUM Growth
+$150M
(+60%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
31.99%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
86
New
43
Increased
23
Reduced
4
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$8.83M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$8.48M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$7.78M |
| 4 |
Post Holdings
POST
|
+$6.6M |
| 5 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$6.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$9.57M |
| 2 |
Biogen
BIIB
|
+$8.64M |
| 3 |
Cheniere Energy
LNG
|
+$5.16M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$5.13M |
| 5 |
Insulet
PODD
|
+$5.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.64% |
| 2 | Financials | 19.47% |
| 3 | Communication Services | 15.52% |
| 4 | Technology | 15.03% |
| 5 | Consumer Staples | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Insmed
INSM
$28.9B
| $2.76M | 0.69% |
+157,529
| New | +$2.43M |
|
|
SAGE
52
DELISTED
Sage Therapeutics
SAGE
| $2.75M | 0.69% |
+38,651
| New | +$2.26M |
|
53
BioCryst Pharmaceuticals
BCRX
$2.71B
| $2.71M | 0.68% |
+322,164
| New | +$2.24M |
|
|
CLVS
54
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.65M | 0.66% |
+41,625
| New | +$2.53M |
|
|
ABMD
55
DELISTED
Abiomed Inc
ABMD
| $2.61M | 0.65% |
+20,828
| New | +$2.41M |
|
|
BLCM
56
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $2.6M | 0.65% |
+21,026
| New | +$2.75M |
|
|
GHDX
57
DELISTED
Genomic Health, Inc.
GHDX
| $2.51M | 0.63% |
+79,693
| New | +$2.36M |
|
58
Vanda Pharmaceuticals
VNDA
$314M
| $2.46M | 0.62% |
+176,056
| New | +$2.51M |
|
|
AMRN
59
Amarin Corp
AMRN
$297M
| $2.46M | 0.62% |
+38,462
| New | +$2.44M |
|
|
DBVT
60
DBV Technologies
DBVT
$889M
| $2.46M | 0.61% |
+6,972
| New | +$2.45M |
|
|
MDCO
61
DELISTED
Medicines Co
MDCO
| $2.45M | 0.61% |
50,060
-79,878
| -61% | -$3.64M |
|
62
Ironwood Pharmaceuticals
IRWD
$714M
| $2.44M | 0.61% |
+171,060
| New | +$2.34M |
|
|
AET
63
DELISTED
Aetna Inc
AET
| $2.44M | 0.61% |
+19,143
| New | +$2.4M |
|
64
UnitedHealth
UNH
$364B
| $2.44M | 0.61% |
+14,854
| New | +$2.43M |
|
|
WCG
65
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.43M | 0.61% |
+17,309
| New | +$2.46M |
|
|
AMAG
66
DELISTED
AMAG Pharmaceuticals
AMAG
| $2.36M | 0.59% |
+104,602
| New | +$2.5M |
|
|
SGEN
67
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.34M | 0.59% |
+37,246
| New | +$2.32M |
|
68
United Therapeutics
UTHR
$21.9B
| $2.33M | 0.58% |
+17,242
| New | +$2.61M |
|
|
ONC
69
BeOne Medicines Ltd
ONC
$40.6B
| $2.31M | 0.58% |
+63,211
| New | +$2.3M |
|
70
Vanguard Real Estate ETF
VNQ
$38.6B
| $782K | 0.2% |
9,473
+68
| +0.7% | +$5.64K |
|
71
Accenture
ACN
$110B
| – | – |
-39,799
| Closed | -$4.66M |
|
|
72
Biogen
BIIB
$30.9B
| – | – |
-30,470
| Closed | -$8.64M |
|
73
Dollar Tree
DLTR
$24.7B
| – | – |
-58,581
| Closed | -$4.52M |
|
74
eBay
EBAY
$45.5B
| – | – |
-167,362
| Closed | -$4.97M |
|
75
Home Depot
HD
$342B
| – | – |
-36,509
| Closed | -$4.89M |
|
Similar funds
PPL
ACH
TM
SVG
DLDF
AGFIA
ARC
ST
University of Notre Dame du Lac's Q1 2017 Portfolio in Review
As of Q1 2017, University of Notre Dame du Lac held 86 positions worth $400M, up 60% from $250M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
University of Notre Dame du Lac deployed $128M of net new capital in Q1 2017, opening 43 new positions and adding to 23 existing holdings. Its largest new stake was Gilead Sciences: 125,637 shares worth $8.53M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 7.4% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $4.2M trimmed.
- University of Notre Dame du Lac's largest Q1 2017 buy was Gilead Sciences: 125,637 shares worth $8.53M.
- University of Notre Dame du Lac added most to Alphabet (Google) Class C in Q1 2017, an estimated $7.78M increase.
- University of Notre Dame du Lac's biggest Q1 2017 reduction was Meta Platforms (Facebook), cutting an estimated $4.2M.
- University of Notre Dame du Lac fully exited PayPal in Q1 2017, selling an estimated $9.57M.
- University of Notre Dame du Lac's ten largest holdings make up 31% of its $400M portfolio in Q1 2017.
- University of Notre Dame du Lac opened 43 new positions and closed 16 in Q1 2017.
- University of Notre Dame du Lac's portfolio value rose 60% quarter-over-quarter to $400M.
Based on University of Notre Dame du Lac's 13F filing for Q1 2017, filed 12 May 2017.